Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial (Q73081781)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 1999

Language	Label	Description	Also known as
English	Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial	scientific article published on 01 October 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

K L Neuhaus

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G P Molhoek

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

U Zeymer

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

U Tebbe

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K Wegscheider

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R Schröder

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Camez

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G J Laarman

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G M Grollier

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D J Lok

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H Kuckuck

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P Lazarus

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

0 references

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

966-973

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct thrombin inhibitors in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of hirudin and heparin as adjuncts to streptokinase thrombolysis in a canine model of coronary thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiographic dose-finding study with r-hirudin (HBW 023) for the improvement of thrombolytic therapy with streptokinase (HIT-SK). Interim results

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coron

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HBW 023 (recombinant hirudin) for the acceleration of thrombolysis and prevention of coronary reocclusion in acute myocardial infarction: results of a dose-finding study (HIT-II) by the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Early, Complete Infarct Vessel Patency: Arriving at a Gold Standard for Future Clinical Investigation in Myocardial Reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thromb

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900319-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(99)00319-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10520777%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73081781&oldid=2224945390"